Drugmakers must meet global rules after fatalities


Unpacking grief: Sushanth reacting while speaking next to a framed photo of his daughter, Yojita, in Parasia. (Below) A bottle of Coldrif cough syrup and a prescription which the mother, Reema Yaduvanshi, 26, received from doctor Praveen Soni for her six-month-old son, Kartik. — Reuters

THE nation has refused drugmakers’ requests to extend a year-end deadline for them to upgrade their manufacturing facilities to international standards, four sources said, amid public anger over the recent deaths of at least 24 children who consumed locally produced cough syrup.

New Delhi had in late 2023 ordered pharmaceutical companies to ensure their plants meet World Health Organisation-recommended standards, which would require them to invest in protocols to prevent cross-contamination and enable batch-testing of samples, among other measures.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Aseanplus News

Conditions not yet met for border meeting with Cambodia: Thai FM spokesperson
Bursa Malaysia poised to wrap 2025 on a multi-year high
Jackie Chan admits strict parenting style caused rift with son Jaycee
Durian sales surge in Singapore after Musang King prices plunge in Malaysia
Ringgit opens higher as US$ slips after FOMC minutes
Timor-Leste and Zchwantech enter landmark AI partnership
Junta accuses rebels of ‘malicious’ election attacks
Voyage linking past with present
Bangladesh declares three-day state mourning for Khaleda
Blame game mars ceasefire deal

Others Also Read